|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q9UMZ3 |
| Protein name |
Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) |
| Protein function |
Dephosphorylates phosphatidylinositol phosphates, such as phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 3,5-diphosphates, with preference for PIP3 (PubMed:23897475). Phosphate can be hydrolyzed from the D3 and D5 posit |
| PDB |
4IKC
|
| Family and domains |
Pfam
| Accession |
ID |
Position in sequence |
Description |
Type |
| PF00041 |
fn3 |
9 → 88 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
99 → 185 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
612 → 693 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
709 → 787 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
803 → 884 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
898 → 977 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
992 → 1082 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
1195 → 1273 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
1286 → 1370 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
1383 → 1460 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
1473 → 1568 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
1582 → 1663 |
Fibronectin type III domain |
Domain |
| PF00041 |
fn3 |
1685 → 1775 |
Fibronectin type III domain |
Domain |
| PF18861 |
PTP_tm |
1819 → 1973 |
Transmembrane domain of protein tyrosine phosphatase, receptor type J |
Family |
| PF00102 |
Y_phosphatase |
2060 → 2291 |
Protein-tyrosine phosphatase |
Domain |
|
| Tissue specificity |
TISSUE SPECIFICITY: In developing kidney, it localizes to the basal membrane of podocytes, beginning when podocyte progenitors can first be identified in the embryonic kidney (at protein level). Expressed in lung and kidney. {ECO:0000269|PubMed:12837292, |
| Sequence |
|
| Sequence length |
2332 |
| Interactions |
View interactions |
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Autosomal recessive nonsyndromic hearing loss 84A |
Likely pathogenic; Pathogenic |
rs948217913, rs2121280782, rs1894570068, rs281865414, rs183258549, rs1005570619, rs2541594859, rs1310828595, rs2541600597, rs1896318374 |
RCV003333615 RCV001822875 RCV004785290 RCV000144416 RCV000144417 RCV002444377 RCV002444378 RCV003129593 RCV003226706 RCV001250122 |
| Deafness |
Likely pathogenic; Pathogenic |
rs1565819402, rs1565855932 |
RCV000679835 RCV000679834 |
| Ear malformation |
Likely pathogenic |
rs2121304960, rs1592779077 |
RCV001814555 RCV001836908 |
| Hearing loss, autosomal dominant 73 |
Pathogenic; Likely pathogenic |
rs2121223982, rs916582229 |
RCV001542772 RCV001262191 |
| Hearing loss, autosomal recessive |
Likely pathogenic; Pathogenic |
rs1565819402, rs1565855932 |
RCV001291238 RCV001291239 |
| Monogenic hearing loss |
Pathogenic |
rs1896318374 |
RCV006266666 |
| PTPRQ-related disorder |
Likely pathogenic; Pathogenic |
rs1450763362, rs1283638306, rs377572771 |
RCV003400152 RCV003897005 RCV004754548 |
|
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Hearing impairment |
Uncertain significance; Benign; Likely benign |
rs1245108213, rs2120546591, rs974503422, rs2121305975, rs368946018 |
RCV001375334 RCV001375242 RCV001375082 RCV001375456 RCV001375077 |
| Hepatocellular carcinoma |
Benign |
rs57971665 |
RCV005899915 |
| Malignant lymphoma, large B-cell, diffuse |
Benign |
rs4341604, rs56105723 |
RCV005916563 RCV005861180 |
| Malignant tumor of esophagus |
Benign |
rs57971665 |
RCV005899916 |
| Ovarian serous cystadenocarcinoma |
Benign; Uncertain significance |
rs4341604, rs74961900, rs10506831, rs1163297, rs201859718 |
RCV005916564 RCV005924840 RCV005921956 RCV005922242 RCV005931063 |
| See cases |
Conflicting classifications of pathogenicity |
rs1894506287 |
RCV002252651 |
| Sensorineural hearing loss disorder |
Uncertain significance |
rs1238341806 |
RCV001353200 |
| Uterine carcinosarcoma |
Benign |
rs57971665 |
RCV005899917 |
|
| Disease Name |
Relationship Type |
References |
| Adenocarcinoma of Lung |
Associate |
37350390 |
| Carcinoma Hepatocellular |
Associate |
36153509 |
| Deafness |
Associate |
25788564, 25919374, 37106574 |
| Hearing Loss |
Stimulate |
19888295 |
| Hearing Loss |
Associate |
20346435, 25788564, 25919374, 29309402, 29849575, 33478437, 33997018, 37106574, 40165225 |
| Hearing Loss Sensorineural |
Associate |
25788564, 25919374, 29849575, 37106574 |
| Heart Diseases |
Associate |
33035386 |
| Hydrocephalus |
Associate |
33035386 |
| Hydrocephalus Normal Pressure |
Stimulate |
33035386 |
| Nonsyndromic Deafness |
Associate |
33478437 |
| Nonsyndromic sensorineural hearing loss |
Associate |
20346435, 29849575, 31655630 |
| Optic Disk Drusen |
Associate |
39865650 |
| Parkinson Disease |
Stimulate |
33035386 |
| Tooth Loss |
Associate |
29309402 |
| Townes Brocks syndrome |
Associate |
33478437 |
| Vestibular Diseases |
Associate |
20346435, 25788564 |
|